key: cord-0890755-kk1lvm66 authors: Youk, Jeonghwan; Kim, Taewoo; Evans, Kelly V.; Jeong, Young-Il; Hur, Yongsuk; Hong, Seon Pyo; Kim, Je Hyoung; Yi, Kijong; Kim, Su Yeon; Na, Kwon Joong; Bleazard, Thomas; Kim, Ho Min; Fellows, Mick; Mahbubani, Krishnaa T.; Saeb-Parsy, Kourosh; Kim, Seon Young; Kim, Young Tae; Koh, Gou Young; Choi, Byeong-Sun; Ju, Young Seok; Lee, Joo-Hyeon title: Three-dimensional human alveolar stem cell culture models reveal infection response to SARS-CoV-2 date: 2020-10-21 journal: Cell Stem Cell DOI: 10.1016/j.stem.2020.10.004 sha: 7a10b29ef30eb6f952ad0b2c4e72835626a0197e doc_id: 890755 cord_uid: kk1lvm66 Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), which is the cause of a present global pandemic, infects human lung alveolar type 2 (hAT2) cells. Characterizing pathogenesis is crucial for developing vaccines and therapeutics. However, the lack of models mirroring the cellular physiology and pathology of hAT2 cells limits the study. Here, we develop a feeder-free, long-term three-dimensional (3D) culture technique for hAT2 cells derived from primary human lung tissue, and investigate infection response to SARS-CoV-2. By imaging-based analysis and single-cell transcriptome profiling, we reveal rapid viral replication and the increased expression of interferon-associated genes and pro-inflammatory genes in infected hAT2 cells, indicating robust endogenous innate immune response. Further tracing of viral mutations acquired during transmission identifies full infection of individual cells effectively from a single viral entry. Our study provides deep insights into the pathogenesis of SARS-CoV-2, and the application of defined 3D hAT2 cultures as models for respiratory diseases. Currently, Coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading globally ) and more than 35.8 million confirmed cases with 1.05M deaths have been reported worldwide as of 7 th Oct 2020. The alveoli in lung tissues are the main target tissues for these emerging viruses especially in SARS-CoV-2-associated pneumonia patients (Muus et al., 2020) . To develop strategies for efficient prevention, diagnosis, and treatment, the characteristics of new viruses, including mechanisms of cell entry and transmission, kinetics in replication and transcription, host reactions and genome evolution, should be accurately understood ideally in its target cell types. Essential features of SARS-CoV-2 virus, for instance ACE2 dependency for cellular entry, patterns of viral transcription and structure of the Spike protein, have been identified (Hoffmann et al., 2020; Kim et al., 2020a; Walls et al., 2020; Wang et al., 2020) . However, most findings have been obtained from experiments using nonphysiological cell lines , model animals, such as transgenic mice expressing human angiotensin-converting enzyme 2 (Bao et al., 2020) , ferrets (Kim et al., 2020c) and golden hamsters (Sia et al., 2020) , or from simple observation in clinical cohorts (Wolfel et al., 2020) and/or inference from in-silico computational methods (Andersen et al., 2020; Forster et al., 2020; Shang et al., 2020) . A number of studies utilizing stem cell-based models have been recently established for various tissues Jacob et al., 2020; Lamers et al., 2020; Ramani et al., 2020; Yang et al., 2020) . However, without competent human alveolar model systems derived from primary tissues, controlled experiments for understanding virus-host interactions, subsequent immune reactions, or for detecting personal genome variants causing susceptibility to the viral infection are challenging. Studies of COVID-19, and respiratory infectious diseases more generally, have been limited by the lack of physiological models that recapitulate normal alveolar physiology and pathology. Development of organotypic mini-organ models, or organoids, has enabled various physiologic and pathological studies using human-derived tissues in vitro (Bartfeld et al., 2015; Fatehullah et al., 2016; Heo et al., 2018) . Organoid models established from the human kidney, intestine, and airway have been used to investigate SARS-CoV-2 viral pathogenesis (Elbadawi and Efferth, 2020; Lamers et al., 2020; Monteil et al., 2020) . However, the cellular response of human alveolar type 2 (hereafter referred to as hAT2) cells to SARS-CoV-2 remains elusive, due to difficulty in the long-term expansion of pure hAT2 cells. A recent study utilized a model of hAT2 cells derived from human induced pluripotent stem cells to show the aspects of SARS-CoV-2 infection . However, inability to differentiate into alveolar type 1 (AT1) cells and to assess potential ageand/or disease-related viral effects limits an understanding of infection response in primary alveolar lung tissues. In this study, we develop a technique for long-term, feeder free human 3D alveolar type 2 cell cultures (hereafter referred to as h3ACs) established from single primary hAT2 cells which serve as stem cells in adult alveolar tissues (Barkauskas et al., 2013) . Using our h3AC models, we demonstrate phenotypic changes of hAT2 cells induced by SARS-CoV-2 infection by multi-dimensional methods. We developed chemically defined culture conditions for growing hAT2 cells, which were significantly improved from previous feeder-based systems (Barkauskas et al., 2013; Kathiriya et al., 2020) . It allowed the self-organization of hAT2 single-cells into alveolar-like 3D structures with defined factors that support the molecular and functional identity of primary tissue-derived hAT2 cells over multiple passages. Briefly, single-cell dissociated hAT2 cells derived from distal parenchymal regions of healthy donor lungs were isolated by fluorescence-activated cell sorting (FACS) for the hAT2 cell surface marker HTII-280 (CD31 -CD45 -EpCAM + HTII-280 + ) ( Figure 1A and Figure S1A)( Barkauskas et al., 2013; Gonzalez et al., 2010) . Approximately, HTII-280 + cells represented 75% of total EPCAM + cells ( Figure S1A ). Quantitative PCR (qPCR) analysis confirmed that the hAT2 cell marker SFTPC was highly expressed in isolated HTII-280 + cells, while the basal cell marker TP63 and secretory cell marker SCGB1A1 were highly expressed in HTII-280cells ( Figure S1B ). Isolated HTII-280 + cells were then embedded in Matrigel for 3D culture supplemented with CHIR99021, RSPO1 (R-spondin 1), FGF7, FGF10, EGF, NOG (NOGGIN), and SB431542, factors that have been implicated in lung development and growth of human embryonic lung tip cells (Nikolic et al., 2017) . Under this condition, hAT2 single-cells created 3D cellular structures with heterogeneous size and morphology, including both folded and cystic-like structures ( Figures 1B-D) . They consisted of mature hAT2 cells expressing pro-SFTPC, HTII-280, and J o u r n a l P r e -p r o o f ABCA3, as well as exhibiting uptake of Lysotracker, a fluorescent dye that stains acidic organelles such as lamellar bodies, a secretory vesicle containing surfactant proteins (Figures 1B-D; Figure S1C ) (Barkauskas et al., 2013; Van der Velden et al., 2013) . Further, HTII-280 + hAT2 cells expressing HOPX were also observed in our h3ACs, as well as in alveolar tissue sections (Travaglini et al., 2020) (Figures S1C and S1D) . Notably, hAT2 cells started to form a small cluster revealing the enriched expressions of HTII-280 and Factin in the luminal side of h3ACs ( Figure 1E) . Over the growth of h3ACs, although the location of HTII-280 expression became varied (Figure S1E) , the distribution of F-actin was maintained specifically in the luminal and lateral surfaces of hAT2 cells, consistent with a previous observation in distal embryonic lung epithelium (El-Hashash and Warburton, 2011) ( Figure 1F ). In contrast, SCRIB, which establishes apical-basal polarity (Rodriguez-Boulan and Macara, 2014) , was restricted to the basolateral surface of hAT2 cells ( Figure 1F ). We found that CRB3, which has been previously reported to mark an epithelial apical domain including proximal airway epithelium in lung development (Pocha and Knust, 2013; Szymaniak et al., 2015) , was expressed broadly within hAT2 cells (Figures 1E and 1F) . We found WNT activation as an essential factor for clonal expansion of hAT2 cells, as evidenced by no colony formation in the absence of the WNT activator CHIR99021 in primary culture ( Figure S1F ). HTII-280cells were also cultured under conditions supporting 3D cultures of human bronchial (airway) cells (hereafter referred to as h3BCs) that have previously been reported (Sachs et al., 2019) . They grew quickly by day 14 with cystic-like structures consisting of a number of airway cell types, including KRT5 + TP63 + basal cells and SCGB1A1 + secretory cells, as previously reported (Figures S1G-I) (Sachs et al., 2019) . Significantly, our culture condition allowed the long-term expansion of hAT2 cells up to 10 months, although colony forming efficiency varied between individual donor samples ( Figures 1G and 1H) . Importantly, over serial passaging via single cell dissociation, hAT2s revealed clonal expansion, leading to 3D structures consisting of mature hAT2 cells expressing pro-SFTPC and uptake of Lysotracker following 6 months of continuous culture ( Figure 1I ). In addition, cultured hAT2 cells for 6 months maintained normal karyotypes ( Figure S1J ) suggesting chromosome-level genomic stability for the period. Importantly, upon culture in 2D which promotes AT1 cell phenotype (Dobbs, 1990) , clonally expanded hAT2 cells differentiated into hAT1 cells expressing AGER and AQP5, indicating retention of AT1 cell differentiation capacity of hAT2 cells in our culture condition ( Figure 1J ). Over longterm culture, we found that colony forming efficiency reduced at later passages, with colony J o u r n a l P r e -p r o o f size decreasing ( Figure 1H and Figure S1K ). In 8-month-old 3D cultures, some cells lost the expression of pro-SFTPC, although no expression of airway markers such as TP63 was detected ( Figure 1K ). We next infected our established h3ACs (and h3BCs) with SARS-CoV-2 (Figure 2A) . To this end, we physically and chemically broke h3ACs and h3BCs into pieces to enhance the access of SARS-CoV-2 to the apical cell surfaces, followed by viral incubation at a multiplicity of infection (MOI) of 1.0 and 0.1. The viral particles were collected and prepared from a Korean patient (known as KCDC03) who was diagnosed with COVID-19 on January 26, 2020, after traveling to Wuhan, China (Kim et al., 2020b) . Vero cells, an interferondeficient 2D cell line conventionally used as viral host, were also experimentally infected as a positive control, although this was not directly comparable to our 3D infection models due to different technical procedures. In the plaque forming assay with MOI of 1.0, infectious viral particles increased to significant titers in h3ACs within the 1st day post infection (dpi), suggesting that exponential viral replication occurs during <24 hrs from viral entry in hAT2 cells (Figures 2B and 2C) . The increment of viral particles was observed in h3BCs as reported (Suzuki et al., 2020) , but their titers were ~100 times lower than h3ACs (Figures 2B and 2C ). Infected Vero cells exhibited an even higher SARS-CoV-2 viral burden than h3ACs (Figures 2B and 2C ). In line with viral particles, the viral RNA levels in the infected h3ACs also highly increased at 1 dpi ( Figure 2D ). Further, viral transcripts were also detected in the supernatant of h3ACs ( Figure 2D ), suggesting active secretion of viral transcripts (or particles) from the infected hAT2 cells. In the lower infection experiments with MOI of 0.1, a substantially lower viral burden was observed for the three days, suggesting that a fraction of hAT2 cells were likely left uninfected by 3 dpi (Figure 2D) . Notably, infected h3ACs did not show substantial cytopathies, such as cell degeneration and syncytium formation , and maintained cell viability, unlike Vero cells ( Figure 2E and Figure S2 ). Immunofluorescent (IF) staining of the infected h3ACs revealed widespread expression of ACE2 and TMPRSS2 proteins, which are necessary for SARS-CoV-2 infection (Figures 3A and 3B) (Hoffmann et al., 2020) . Despite conventional wisdom, these proteins were not J o u r n a l P r e -p r o o f present exclusively in membrane but also in the cytoplasm as reported (Hamming et al., 2004; Manna and Caradonna, 2020; Zhou et al., 2020) . In the infected h3ACs (MOI of 1.0 at 1 dpi), viral components were clearly observed by IF staining of nucleocapsid protein (NP), and double-stranded viral RNA (dsRNA) of SARS-CoV-2. These two viral components were robustly detected in the cytoplasm of hAT2 cells with expression of pro-SFTPC, ACE2 and TMPRSS2 (Figures 3C and 3D; Figures S3A and S3B) . IF staining of infected h3ACs revealed that approximately 94% of h3ACs (n=61 out of 65 h3ACs) harbored cells with detectable levels of the viral components ( Figure S3C ). At the level of individual cells, approximately 61% of the cells within individual h3ACs showed evidence of the viral components ( Figure S3C ). However, more widespread infection may have been present, as cells with minimal viral components may have fallen below our detection threshold (Discussion). When h3ACs were treated by camostat mesylate, a serine protease inhibitor active against TMPRSS2, SARS-CoV-2 entry and progression was partially blocked, corroborating that the activity of TMPRSS2 is required for viral infection of hAT2 cells ( Figure S3D ). To further determine subcellular consequences of the SARS-CoV-2 infection at a higher resolution, we performed a transmission electron microscopic (TEM) analysis. Compared with uninfected h3ACs (Figure S4) , infected h3ACs at 2 dpi with MOI of 1.0 showed viral particles and aggregated proteins which appeared as electron-dense objects (Knoops et al., 2008) (Arbour et al., 1999; Monel et al., 2017) . Viral particles were either dispersed or encapsulated in a vesicular structure in cytoplasm ( Figures 4C, 4D , and 4G). Double-membrane vesicles (DMVs), subcellular structures known as sites for early viral replication, were rarely observed in the vicinity of zippered endoplasmic reticulum in an infected cell ( Figure 4I ) (Maier et al., 2013; Ogando et al., 2020) . Virus secretion was also observed in the luminal spaces of h3ACs ( Figures 4E and 4J ). Intriguingly, a fraction of cells in h3ACs (~19% of cells within the four h3ACs explored) showed much higher viral burdens than other cells ( Figure 4C) , with as many as 500 copies in the 100 nm section, implying >10,000 SARS-CoV-2 particles in the cell under an assumption of uniform intracellular viral distribution. It remains to be studied whether these J o u r n a l P r e -p r o o f viral particles are to be secreted, or are competent for infection of other cells. However, if 10% of them are actively released, the burst size of SARS-CoV-2 from hAT2 cells would be larger than previously suggested for murine hepatitis virus, a viral species in beta coronavirus (Bar-On et al., 2020) . We next explored the gene expression changes after SARS-CoV-2 infection in h3ACs. To this end, strand-specific Illumina mRNA libraries were constructed from infected h3ACs with MOI of 1.0 and sequenced (overall 7 samples; at 0, 1, and 3 dpi with 2, 3, and 2 biological replicates, respectively). For comparison, the transcriptome of infected Vero cells was also sequenced. A set of human genes were differentially expressed among the three time points (Figure 5A ), although most genes showed good correlations in gene expression levels (Table S1, Figure S5A ). Cytokeratin genes (including KRT16, KRT6A, KRT6B, and KRT6C), genes involved in keratinization (including SPRR1A), cytoskeleton (including S100A2) and cell-cell adhesion genes (including DSG3), were significantly reduced to ~2-3% in h3ACs at 3 dpi compared to the levels at 0 dpi (Figures 5A and 5B ). Many more genes were upregulated in the infected h3ACs specifically at 3 dpi. In particular, transcription of a broad range of interferonstimulated genes (ISGs), known to be typically activated by type I and III interferons (Iwasaki et al., 2017) , was remarkably increased. These genes include interferon induced protein genes (such as IFI6, IFI27, IFI44, IFI44L), interferon induced transmembrane protein genes (such as IFITM1), interferon induced transmembrane proteins with tetratricopeptide repeats genes (IFIT1, IFIT2, IFIT3), 2'-5'-oligoadenylate synthetase genes (OAS1, OAS2), and miscellaneous genes known to be involved in innate cellular immunity (MX1, MX2, RSAD2, ISG15). These genes were expressed to >20 times higher levels in h3ACs at 3 dpi than at 0 dpi. Many other known ISGs also showed moderate inductions (2-20 times), including BTS2, OAS3, HERC5, HERC6 and USP18. Antiviral functions are known for these ISGs (Schneider et al., 2014) including (1) inhibition of virus entry (MX genes, IFITM genes), (2) inhibition of viral replication and translation (IFIT genes, OAS genes, ISG15, HERC5, HERC6, USP18) and (3) inhibition of viral egress (RSAD2 and BST2). Of the 20 interferon genes in the human genome, an interferon beta (IFNB1) and three interferon lambda genes (IFNL1, IFNL2, and IFNL3) showed significant transcriptional induction, although their absolute changes were not substantial ( Figure 5C ). The surface receptors of interferons were stably J o u r n a l P r e -p r o o f expressed in h3AC cells without reference to viral infection ( Figure 5C ). Downstream signaling genes of the receptors were appreciably upregulated (2-7 times), for example, STAT1, STAT2 and their associated genes, such as IRF1 and IRF9. Of note, IRF1 is known to be specific to type I interferon responses (Forero et al., 2019) , while type I and type III ISGs are generally overlapping (Park and Iwasaki, 2020) . In addition to ISGs, genes in the viral sensing pathway in cytosol showed increased expression in the infected h3ACs at 3 dpi, for example, DDX58 (official gene name of RIG-1, ~13 times), IFIH1 (also known as MDA5, ~5 times), TLR3 (Toll-like receptor 3,~3 times), IRF7 (Interferon regulatory factor 7, ~7 times), and IL6 (~4 times at 1 dpi; proinflammatory factor). Of note, the innate immune response observed was completely autologous because immune cells are absent in our h3AC system, thus mimicking the very early phase of SARS-CoV-2 alveolar infection. As a validation study, we performed the analyses of qPCR and IF staining in the infected h3ACs ( Figure 5D and Figure S5B ), which supported the transcriptome changes. To understand the biological reliability of these upregulated genes, we compared the gene list with transcriptomes produced from the lung tissue of COVID-19 patients (obtained from 8 tissues from two COVID-19 pneumonia patients) (Blanco-Melo et al., 2020) . Unlike our models, tissue transcriptome showed a substantially higher level of variance presumably caused from the diverse cell-type composition in the tissue (i.e. airway epithelial, immune, mesenchymal and endothelial cells; Figure S5C ). Of the 97 DEGs in our h3AC models, 26.8% were confirmed in the infected human tissues ( Figure S5D ; Table S2 ). We then further explored the utility of our h3AC models by comparison with other cellular models. In h3BCs, for example, most of the DEGs observed in h3ACs were not substantially altered ( Figures S5E; Table S3 ). Indeed, only a few genes were transcriptionally altered in h3BCs at 3 dpi ( Figure S5F) , presumably due to the insufficient SARS-CoV-2 infection as mentioned above ( Figure 2C) . Similarly, 2D cell-lines (Emanuel et al., 2020b) established from lung and colon cancers (NCI-H1299 and Caco-2, respectively) showed no evidence of sufficient SARS-CoV-2 infection ( Figure S5G ). Vero cells (sequenced in this study) showed expression changes of many genes, but transcription of ISGs was not altered presumably due to the absence of interferon genes in the genome ( Figure S5G ). Calu-3, established from lung cancer, showed quite similar gene expression changes with our h3ACs ( Figure J o u r n a l P r e -p r o o f S5G). Of these models, our h3ACs showed the highest concordance with human lung tissues ( Figure S5H ). In addition, a prolonged observation (>1 dpi) of viral infection is not feasible with these cell-lines, because infected 2D cells are easily suspended from the culture plate. We further analyzed the viral RNAs from the transcriptomes of infected h3AC and h3BC models. In agreement with the plaque assay ( Figures 2B and 2C) , the proportion of viral reads in whole-transcriptome sequences plateaued by 1 dpi in the h3ACs ( Figure 5E ). Approximately 50% of the sequencing reads were mappable to the SARS-CoV-2 genome in h3ACs from 1 dpi, indicating prevailing viral gene expression in infected AT2 cells as observed in Vero cells (Kim et al., 2020a) . In contrast, the proportion of viral reads was less than 0.3% in the infected h3BCs until 3 dpi ( Figure 5E ). Viral transcripts were not mapped uniformly to the viral genome sequence, but 3' genomic regions where canonical subgenomic RNAs (sgRNAs) showed much higher read-depth in all samples, consistent with the previous report ( Figure S5I ) (Kim et al., 2020a) . The vast majority of viral RNA sequences were in the orientation of positive-sense RNA strands ( Figure S5I ; for example, 99.98% vs 0.02% for positive-and negative-sense RNAs, respectively, from h3ACs at 1 dpi). This is in good agreement with the nature of SARS-CoV-2, which is an enveloped, non-segmented, and positive-sense RNA virus. Therefore, its genomic RNA in viral particles and sgRNA transcripts being translated in the cytoplasm should be positive-sense RNAs. Negative-sense RNAs are intermediate templates for replication and/or transcription of positive-sense RNAs. Cross-comparison of viral RNA sequences obtained from the 11 infected h3ACs (n=5) and h3BCs (n=6) revealed 20 viral base substitutions (Table S4) . No mutation was at 100% variant allele fraction (VAF) and exclusive to an infection experiment. Instead, sequence alterations showed a broad range of quasispecies heterogeneity in each culture (VAF ranges from 0.1% to 73.1%; Figure 5F ), and a large proportion of the mutations (n=16; 80%) were shared by two or more infected models (by the cut-off threshold of 0.1%). Therefore, we speculate that most of the base changes were originally present in the pool of viral particles before their inoculation to our models. Given the fact that these viral particles were prepared from one of the earliest COVID-19 patients, our finding suggests that mutations can J o u r n a l P r e -p r o o f accumulate in the pool of viral genomes in a small number of rounds of viral transmissions, and appear with dramatic changes in quasispecies abundance. A substantially higher proportion of specific mutations in a sample may suggest a bottleneck in viral entry or stochasticity in viral replication. To understand transcriptional changes of the infected h3ACs at a single-cell resolution, we (1,280 vs. 119 UMIs, respectively), despite cells in Cluster 6 containing relatively lower total UMI counts than ones in the other clusters (4,534 vs. 17,923 UMIs, respectively; Figures 6D and 6E). When normalized with cellular UMI counts, the proportion of highly infected cells (≥2 9 viral reads per cell) in Cluster 6 was 28 times higher than that in Cluster 5 ( Figure 6D) . Interestingly, the highly infected cells in Cluster 6 showed reduced expression of canonical J o u r n a l P r e -p r o o f hAT2 marker genes, including SFTPB (Surfactant Protein B) and NKX2-1 (NK2 homeobox 1) ( Figure 6E ). Further, we found 8.2% of actively proliferating hAT2 cells (MKi67 + h3ACs) in uninfected h3ACs (Cluster 1), which was more-or-less maintained across the infection progression in infected h3ACs (Cluster 2, 10.6%; Cluster 3, 12.8%; Cluster 4, 3.6%; Cluster 5, 30.3%; Cluster 6, 5.1%) ( Figure S6F ). Of note, we found 52 cells (0.4%) showing ACE2 transcripts, 2,661 cells (18.8%) expressing TMPRSS2 transcripts, and 17 cells (0.1%) expressing both in single-cells ( Figure 6E ), despite the widespread protein expression (Figures 3A and 3B ). These proportions are low at face value, but are consistent with a previous observation (Ziegler et al., 2020) . Although the previous report also suggested that ACE2 RNA expression can be stimulated as an infection-mediated response, particularly in human airway cells, such a trend was not observed in our dataset. Our single-cell clusters illustrated the characteristic transcriptional changes in the course of SARS-CoV-2 infection (Figures 7A and 7B ; Table S5 ). For example, AQP5 transcription, highly expressed in a subset of hAT2 cells that selectively express Wnt pathway genes and were proposed as alveolar stem cells (Travaglini et al., 2020) , was robust in uninfected h3AC cells (Cluster 1), yet downregulated in the other clusters of infected cells. In the acute phase of viral infection (4 hpi; Cluster 2), genes responsive to the ER stress, such as HSPA1A, HSPA5 and HERPUD1, were specifically upregulated suggesting that viral infection affects cellular phenotypes from the early hours after cellular entry. In Clusters 4 and 5, hAT2 cells at 60 hpi upregulated ISGs, such as IFI27 and IFI6. In the cluster of disintegrating cells (Cluster 6), expression levels of ISGs were mostly reduced. Instead, these cells showed transcriptional induction of apoptosis mediators, such as PPP1R15A and GADD45B, suggesting an active catastrophic cellular pathway due to the extreme viral burdens. Gene ontology analyses with the variable genes in single-cell transcriptome sequencing mostly highlighted infection-related pathways ( Figure S6E ). Finally, we statistically inferred the number of viral particles effectively entering each alveolar cell for infection. Although thousands of viral copies were often observed in the infected cells (Figure 4) , it is generally not known how many viral particles are necessary for effective infection of an alveolar cell. In an extreme scenario, one viral particle is sufficient. Alternatively, infection may be initiated with the entry of multiple viruses. We tracked the effective viral number of cellular entries using a mutation (NC_045512.2: 23,707C>U; a silent mutation in Spike protein) as a viral barcode in the viral quasispecies ( Figure 7C ). From our sequencing, the mutation was estimated to be present at 4.3% VAF in the initial viral pool for inoculation. If the first scenario dominantly applies, the infected alveolar cells will be dichotomized, i.e., 95.7% cells with solely wild-type virus and the rest of the cells with showing solely mutant allele vs mixture of the quasispecies, respectively; Figure 7C ). In a more sophisticated statistical analysis, infection by single viral entry is estimated as >2 times more frequent than by multiple viral entry (69% vs. 31%, respectively; Figure 7D ). Our calculation indicates that a single viral particle is mainly responsible for SARS-CoV-2 infection in most hAT2 cells, although multiple viral entry is also possible. It may also reflect viral interference in SARS-CoV-2 alveolar infection. In this study, we have established the experimental condition for feeder-free, long-term 3D cultures of adult hAT2 cells. We demonstrated that WNT activity is crucial for hAT2 maintenance, as consistent with previous studies of murine AT2 cells (Frank et al., 2016; Nabhan et al., 2018; Zacharias et al., 2018) . Although our h3ACs may not produce the full cellular spectrum present in the adult alveoli, h3ACs established cellular polarity and maintained functional mature and genomic stable hAT2 cells over multiple passages. SARS-CoV-2 infected h3ACs showed remarkable cellular and transcriptional changes far more clearly than other models, including h3BCs and 2D Vero cell lines, showing cellular tropism in the viral replication and transcription as well as the resultant reaction from the host cell. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 (Hoffmann et al., 2020) . Although their protein levels are widespread in hAT2 cells (Hamming et al., 2004; Ren et al., 2006) , J o u r n a l P r e -p r o o f their transcription is not very active in our single-cell transcriptome analysis of h3ACs, in agreement with recent reports Ziegler et al., 2020) . Estimating the proportion of cells harboring low abundance transcripts with single-cell RNAseq is generally challenging, frequently resulting in underestimation. On the contrary, we observed that single-cell transcriptome sequencing enables more sensitive and scalable detection of the infected cells compared to immunostaining and TEM analyses ( Figure S6D ). We believe that newly infected cells, which include abundant viral transcripts prior to the production of viral protein components, are more likely to be detected by single-cell transcriptome techniques. However, the detection sensitivity is dependent on the burden of viral transcripts in cells as well as the depth of single-cell sequencing. Through the multi-dimensional analyses of the infected h3ACs, we found that (1) viral replication is active during the first day after cellular infection, (2) expression of type I and III interferons begins at 1 dpi, and (3) expression of ISGs follows at 3 dpi. The timing of ISG induction in alveolar cells may be more rapid in vivo in concert with exogenous interferons from immune cells. For more physiological understanding, co-culturing SARS-CoV-2 infected h3AC models with immune cells obtained from the same donor would be helpful. Notably, we identified five states of infected cells across the infection progression with MOI of 0.1 and 1.0 (Clusters 2-6). Given the hAT2 cells are more-or-less homogeneous before being infected, this indicates a distinct switch between cell states occurring during infection. If in vivo SARS-CoV-2 infection transforms hAT2 cells into Cluster 6-like cells showing the loss of hAT2 identity, the integrity and function of alveoli will be highly compromised. The route towards the quantum cellular change is of significant interest to be answered in future studies. Although we observe in this study that physiological and molecular changes of alveolar cells appear within 3 days post infection, clinical symptoms of COVID-19 sometimes occur after >10 days of viral exposure (Lauer et al., 2020) . Several possible explanations could underpin the temporal difference. Viral infiltration from the upper respiratory tract to terminal alveoli may take several days; a substantial proportion of alveolar cells may need to be infected before displaying symptoms; or, further interactions with immune cells resulting in inflammation may be necessary for developing symptoms. From single-cell transcriptome sequences, we observed a subset of cells with distinct transcriptional features (Cluster 7), which express lower levels of canonical hAT2 marker genes, including SFTPB ( Figure 6E ) but detectable levels of airway marker genes, including SOX2, KRT5, and TP63 ( Figure S6B) . Some of these cells harbored SARS-CoV-2 transcripts, but expression of the marker genes was not highly affected. We speculate that these cells are hAT2 cells with pathologic phenotypes of alveolar bronchiolization and/or basal-like hAT2 cells, which are stochastically observed in chronic lung diseases (Jensen-Taubman et al., 1998; Xu et al., 2016) . Given the fact that h3ACs used for SARS-CoV-2 infection were established from hAT2 cells isolated from adjacent normal counterparts of lung cancer and/or IPF, it is likely that this transcriptional feature reflects the cellular status of original tissues rather than virus-associated phenotype. In summary, our study highlights the advantages of h3AC models to elucidate the pathogenesis of SARS-CoV-2 infection in alveolar stem cells. Our data will be a great resource for the biomedical community for deeper characterization of the viral disease. We believe that our models will enable more accurate and sophisticated analyses in the near future, especially for studying the response to viral infection within vulnerable groups with aged or diseased lungs, providing the opportunity to elucidate individual patient responses to viral infection. Furthermore, our models can be combined with other techniques, such as coculture experiments with immune cells and in vitro screening of antiviral agents. We believe that our models are also applicable for the study of basic biology and other diseases in hAT2 cells. Our h3AC models were established from lung tissue specimen collected from patients with heterogeneous clinical history and genetic background. These confounding factors have not been thoroughly controlled in the study. Due to the lack of immune cells in our system, molecular interaction between hAT2 and immune cells could not be investigated in this study. With h3AC models from additional donors as well as introducing immune-cells in culture system will likely advance our understanding of the pathogenesis of SARS-CoV-2 infection. Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Young Seok Ju (ysju@kaist.ac.kr). All 3D models generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement. Processed single cell RNA sequencing data including Seurat objects, cellular metadata, and (Table S6) . SARS-CoV-2 virus strain is BetaCov/Korea/KCDC03/2020 (Kim et al., 2020b) . The patient (KCDC03) was diagnosed with COVID-19 on January 26, 2020, after traveling to Wuhan, China. The virus was also sequenced in the previous paper (Kim et al., 2020a) . For virus replication, Vero cells were infected with MOI of 0.01 and grown under DMEM with 2% FBS, 1% P/S for 48 hours at 37°C 5% CO 2 (hereafter, the media is termed as infection media). Media was centrifuged with 2500rpm for 25min, and supernatant without cell debris was stocked at -80°C with 4 x 10 6 pfu / ml. Freshly isolated HTII-280 + and HTII-280cells derived from CD31 -CD45 -EpCAM + cells of human distal lungs were resuspended in base medium (Advanced DMEM/F12 (Thermo Fisher Scientific) supplemented with 10 mM HEPES (Gibco), 1 U/mL Penicillin/Streptomycin (Gibco), 1 mM N-Acetylcysteine (Sigma-Aldrich), and 10 mM Nicotinamide (Sigma-Aldrich)). Growth factor-reduced (GFR) Matrigel (CORNING) was added to the cell suspension at a ratio of 1:1, and 100 µL of suspension was added to a 24-well transwell insert with a 0.4 µm J o u r n a l P r e -p r o o f pore (CORNING) so that there were approximately 10 x 10 4 cells per insert. GFR-Matrigel was allowed to solidify for 1 hr at 37 ºC, after which 500 µL of pre-warmed alveolar media (base medium supplemented with 1 x B27 (Thermo Fisher Scientific), 10% R-SPONDIN-1 (Cambridge Stem Cell Institute tissue culture core facility, manually produced), 50 ng/ml human EGF (PEPROTECH), 100 ng/ml human FGF7/KGF (PEPROTECH),100 ng/ml human FGF10 (PEPROTECH), 100 ng/ml NOGGIN (PEPROTECH),10 µM SB431542 (TOCRIS) and 3 µM CHIR99021 (TOCRIS)) was added to each lower chamber. For assessment of the effect of Wnt activity on hAT2 culture ability, primary cultures were also established without CHIR99021. Cultures were maintained under standard cell culture conditions (37 °C, 5% CO 2 ), with media changes every 2-3 days. Y-27632 (10 µM, Sigma-Aldrich) was added for the first 48 hr of culture to promote cell survival. To avoid the growth of fungal and bacterial infection, 250 ng/mL Amphotericin B and 50 µg/mL gentamicin were added to culture medium for 5 days. For culture in 48-well plates, 5 x 10 3 cells were resuspended in 100% GFR-Matrigel, and allowed to solidify in a 20 µL droplet per well at 37 ºC for 20 min, followed by submersion in 250 µL of pre-warmed medium. Cellular structures with a surface area of more than 500 µm at day 14 of culture were counted at day 14 to assess colony forming efficiency, and were either fixed and stained at day 21 for analysis, or enzymatically dissociated into single cells for further culture without sorting. Cells in 3D cultures were passaged at different days depending on size, with culture days varying from 21-35 days. For passaging, Matrigel was disrupted by incubation with dispase (Sigma-Aldrich) at 37 ºC for 45 min, followed by single cell-dissociation through addition of TrypLE (Gibco) for 5 min at 37 ºC. The reaction was quenched with base medium, and cells were centrifuged at 350 x g for 5 min. Cells were resuspended in fresh GFR-Matrigel at a ratio of 5 x 10 3 (48-well plates) or 10 x 10 4 (24-well transwell inserts) cells as before. Bronchial cells were passaged every 21-28 days due to accelerated growth compared with hAT2 cells, and were cultured in previously reported medium conditions (Sachs et al., 2019) with the following concentration/factor edits; 100 ng/ml human FGF10, 10% R-SPONDIN-1, 10 µM SB431542 (instead of A83-01). Cultured h3ACs for 6 months were retrieved from Matrigel using Cell Recovery Solution (Corning). h3ACs were dissociated into single cells using Accustase (STEMCELL Technologies) at 37'C for 5-10 minutes. After washing with PBS once, h3ACs were incubated with colcemide (Gibco) at 37'C for 45 minutes. After washing with PBS once, J o u r n a l P r e -p r o o f h3AC cells were incubated with KCl to enlarge the cells. After fixation with acetone, cells were stained with Giemsa. Karyotypes were observed using Cytovision (Leica). Freshly sorted HTII-280 + and HTII-280cells were lysed with TRIzol, and RNA was extracted. RNA was reverse transcribed using SuperScript IV (Thermo Fisher Scientific), and were assessed using the following TaqMan probes; SFTPC (Hs00951326_g1), TP63 (Hs01114115_m1), SCGB1A1 (Hs00171092_m1) ( Table S7) . h3ACs were dissociated into single cells with Accutase (STEMCELL Technologies) at 37°C for 5-10 minutes. Cells were washed with PBS and then seeded in Lab-tek 8 well slide glass (Thermo Fisher Scientific) with 25,000 cells per well or seeded in Collagen I coated 8 well slide glass (SPL). The cells were grown under 10% human serum (Sigma), 1% P/S in DMEM. After 4 days incubation, cells were allowed to attach to slides and differentiate. For 3D culture cells, cells were recovered from Matrigel with Cell Recovery Solution (CORNING). 3D culture cells were sheared with 1000 p pipette tips and incubated with Accutase (STEMCELL Technologies) at 37 °C for 5-10 minutes. After washing, the number of 3D culture cells was calculated by hemocytometer C-chip (iNCYTO), and the appropriate amount of SARS-CoV-2 virus particles was prepared from a stock vial. 3D culture cells were resuspended with each media and were infected with virus multiplicity of infection (MOI) of 1.0 or 0.1 for 2 hrs at 37 °C 5% CO 2 . After 2 hrs incubation, 3D culture cells were washed twice with Advanced DMEM/F12 with 1 U/ml Penicillin/Streptomycin, 10 mM HEPES, and 1% Glutamax (v/v) (hereafter referred to as ADF+++) and embedded in 50 µl of GFR-Matrigel (CORNING) in 24-well plate. Each well contained at least 10,000 cells. To release viral particles from the infected cells, Matrigel was physically disrupted, and cells were lysed by freezing at -80 °C and thawing 3 times. Live virus titers were determined by plaque assay and viral RNA titer was calculated using qRT-PCR. For Vero cell infection, Vero cells were prepared in DMEM with 10% FBS and 1% Penicillin/Streptomycin (Gibco). At the day of SARS-CoV-2 infection, media was aspirated from 6-well plates, and SARS-CoV-2 viral particles with MOI of 0.01 in 500ul of DMEM with 2% J o u r n a l P r e -p r o o f FBS and 1% Penicillin/Streptomycin (Gibco) were added to Vero cells on the 6-well plates for 1 hr at 37 °C 5% CO 2 . After 1 hr, infection media was aspirated, and cells were washed with cold PBS twice. Then,2 ml of DMEM with 2% FBS and 1% p/s solution was added to each 6-well. All work was performed in a Class II Biosafety Cabinet under BSL-3 conditions at Korea Center for Disease Control (KCDC). For viral RNA extraction in the infected cells, cells were retrieved from Matrigel using 500 ul Purified viral RNAs were reverse-transcribed using SuperScript IV (Thermo Fisher Scientific). Viral N gene with 2019-nCoV_N3-F and 2019-nCoV_N3-R probes (CDC) was targeted for qRT-PCR ( To validate upregulated interferon genes (INFB1, INFL1, and INFL2/3) and ISGs (IFI44L, IFI6, IFIT1, and MX1), infected h3ACs were harvested at 0 and 3 dpi. Total cellular RNA was extracted as described above. From equal quantity of RNA (50 ng), cDNA was generated using SuperScript™ III Reverse Transcriptase kit (Invitrogen) as described previously (Pfaffl, 2001 ) and stored at −20°C until use. Real time PCR assay (qRT-PCR) was conducted by the ABI applied biosystems using Power SYBR Green PCR Master Mix (Applied Biosystems) ( Table S7 ). The relative amounts of cytokine mRNA present (normalized with GAPDH) was determined by 2 −∆∆Ct method. To prepare viral specimens released from infected h3AC and h3BC cells, Matrigel was disrupted by repetitive pipetting and cells were lysed by -80°C freezing and thawing once. In the case of Vero cells, culture media were directly used as viral specimens to be used in plaque assays. To perform plaque assays, newly seeded Vero cells in 12-well plates were prepared. Test specimens derived from h3ACs, h3BCs, and Vero cells were serially diluted by a scale of 10 − 10 . Then, 250ul of each diluted specimen was dispensed into the designated well, and incubated for 1hr at 37 °C, 5% CO 2 . After 1 hr, the diluted specimens were aspirated. Vero cells were washed with PBS two times, then agar and Modified Eagle's Medium (Thermo Fisher Scientific) were poured into each well. After agar mixture was solidified, the mixtures were fixed with 4% PFA for 3 days, and stained with crystal violet (Sigma-Aldrich). From the number of colonies, live virus titers were calculated. To measure the viability and cytotoxicity in h3ACs and Vero cells after SARS-CoV-2 infection BSA) was added to dilute the media as indicated by the manufacturer's protocol. Diluted media was incubated with the same amount of LDH Detection Reagent (Promega) for 1 hr. After 1 hr incubation, the intensity of luminescence was measured by Spectramax L (Molecular Devices). Control h3ACs were fixed and embedded in a paraffin block (Lee et al., 2014) . Pre-cut 7 µM paraffin sections were de-waxed and rehydrated (sequential immersion in xylene, 100% EtOH, 90% EtOH, 75% EtOH, distilled water) and either stained with hematoxylin and eosin (H&E) or immunostained. For antigen retrieval, slides were submerged into pre-heated citrate antigen retrieval buffer (10 mM sodium citrate, pH 6.0) and allowed to boil for 15 min. Slides were cooled in a buffer for 20 min, washed in running water for 3 min, and permeabilized with 0.3% Triton-X in PBS for 15 min. Following permeabilization, sections of 3D models were blocked for 1 hr in 5% normal donkey serum in PBS at RT, and incubated with primary antibody mixtures overnight at 4 °C at the following dilutions; rabbit pro-SFTPC Figure 5A and Figure S5E ) using R package "ComplexHeatmap".Enriched pathways were acquired from Enrichr website with input of the top 100 variable genes (Kuleshov et al., 2016) . Previously published bulk RNA sequencing data (fastq files) were obtained from the NCBI Gene Expression Omnibus (GEO) server under the accession number GSE147507 for COVID-19 patients and healthy donors and GSE148729 for 2D cell lines including mock and SARS-CoV-2 treatment of Calu-3, Caco-2, and NCI-H1299 at 24 hpi (Blanco-Melo et al., 2020; Emanuel et al., 2020a) . The fastq files were processed as mentioned above. Fold changes and adjusted p-values of DEGs were calculated using R package "DEseq2" (Love et al., 2014) . The results were demonstrated as volcano plots using R package "EnhancedVolcano" (Blighe et al., 2018) . Differentially upregulated genes were selected when fold change and adjusted p-value of each DEG were more than 1.5 and less than 10 , respectively, in SARS-CoV-2 infected samples compared to uninfected samples ( Figures S5D, S5H , and Table S2 ). To investigate single base substitutions and small indels, we used union sets of variants called by Strelka2 (Saunders et al., 2012) and Varscan2 (Koboldt et al., 2012) Then, in-house script was used to filter false-positive calls, and we manually curated the variant positions using Integrative Genomics Viewer (Robinson et al., 2011) . Fastq files were aligned and UMI counts were calculated using Cell Ranger software (3.1.0) provided by the manufacturer (10X Genomics). The 10X gene count data includes 19,941 human genes and SARS-CoV-2 genome as an extra gene. Normalization was done using a log-normalization method (same as 'NormalizeData from 'Seurat' R package) controlling the total human gene UMI count (after scaling) at 10k. After scaling, each count is log2-transformed after added by 1. From the initial 30,027 cells with reported UMI counts across five experimental conditions, we filtered out cells with >25% mitochondria RNA percent (n=2,479), pathologic cell clusters characterized with KRT5-/KRT17+ (n=13,175) (Adams et al., 2020; Habermann et al., 2020) , and contaminated cells (n=199). The remaining 14,174 cells constitutes the core dataset, and used for graphical visualization as well as clustering analyses. Using 'Seurat V3' package (Stuart et al., 2019) , 3,000 variable features were selected, principal components (PCs) were constructed, and UMAP dimension reduction was performed based on 30 PCs. Then, unsupervised clustering analysis was carried out by J o u r n a l P r e -p r o o f constructing a shared nearest neighbor (SNN) graph (using 'FindNeighbors' function with parameters of 'dims=1:20') and identifying clusters of cells (using 'FindClusters' function with 'resolution' parameter of 0.1). Using 'SC3' package (Kiselev et al., 2019) , additional clustering exercise was carried out and marker genes were highlighted. Specifically, 'SC3' clusters were constructed at 'k=9' parameter setting. Then, marker genes most representing each cluster were found and ranked by internal 'auroc' metric. The marker genes with the associated auroc > 0.85 (default) were visualized. Using 150 variable genes calculated by 'SC3' package, enriched pathways in SARS-CoV-2 infected cells were obtained from Enrichr website (Kuleshov et al., 2016) . For investigating C>U at the 23,707 position of SARS-CoV-2 transcripts in each cell, subsetbam tool (10X Genomics) was used to get an individual bam file per each cell. Samtools (Li et al., 2009 ) was used to call the substitution. In house python and R scripts were used for more downstream analyses. To assess whether hAT2 cells tend to be infected by a single viral particle or multiple particles, we employed a likelihood approach. As a proof-of-concept, we assumed only two scenarios exist, one supporting a single viral entry and the other supporting double viral entry, then aimed to estimate the proportion of cells with a single viral particle ( ). Out data consists of the observed reference ( cell ) and alternative ( ) read counts for each of the 547 cells reporting at least one read at the mutation site of NC_045512.2:23,707. Assuming a sequencing error rate (ε) of 0.1%, which will cover any Illumina sequencing errors or misalignment, the likelihood of data given the weight supporting a single virus scenario ( ) was computed as follows. = = × ! "#$# | single entry + 1 − × ! "#$# | double entry ! "#$# | single entry = ! 4 = 5 × ! cell , | 7#8 = ε + ! 4 = 9 × ! cell , | 7#8 = 1 − ε ! "#$# | double entry = ! 4 = 55 × ! cell , | 7#8 = ε + ! 4 = 59 × ! cell , | 7#8 = 0.5 + ! 4 = 99 × ! cell , | 7#8 = 1 − ε G stands for the viral genotype for each cell, and R and V denote for the reference (wildtype) and variant (mutant) alleles in the genotype, respectively. 7#8 refers to the true mutant allele frequency within an infected cell given the genotype after accounting for the sequencing error rate. For both single-and double-entry scenarios, the prior for each genotype was computed using the mutant allele frequency estimated from the whole cell population (7#8 <=<. ; 4.3%=42 variant reads out of 986 reads). For example, the prior of having the genotype with two mutant alleles in a double-entry scenario is computed as follows: ! 4 = 99 = 7#8 <=< Within a cell, the probability of observing the number of reference and variant reads given the mutant allele frequency, ! cell , | 7#8 , was computed using a binomial distribution. To quantify folded and cystic 3D structures of h3ACs, we at least counted 50 organoids for each donor, and the total number of donors is 3. For quantification of colony forming efficiency (CFE) for h3AC, CFE was calculated from total 3 donors at each passage (Data is represented as mean ± SEM). In Plaque assay for live virus titer, the number of viruses was counted from two technical replicates for each designated timepoints (Data is represented as mean ± SEM). In qPCR for virus RNA titer and interferon induced gene validation, 3 technical replicates were used (Data is represented as mean ± SEM). To compare AT2 marker gene's expression, qPCR was conducted with 2 technical replicates (Data is represented as mean ± SEM). Viability and LDH cytotoxicity assay were replicated with 3 biological replicates (Data is represented as mean ± SEM). All the immunofluorescence images were taken at least 5 different biological replicates and representative image was used. To compare MX1 intensity in control (n = 11) and infected (n = 13) h3ACs, Wilcoxon rank sum test was used. For transmission electron microscopy, more than 10 biological replicates were taken. For karyotyping, 6 normal cell karyotypes were observed and representative image was used. RNA sequencing statistical analysis was written in "RNA sequencing and data processing" session in METHOD DETAILS. Single cell RNA J o u r n a l P r e -p r o o f sequencing statistical analysis was written in "Single cell RNA sequencing and data processing" session in METHOD DETAILS. J o u r n a l P r e -p r o o f SUPPLEMENTAL EXCEL TABLE TITLES AND LEGENDS Table S1 . RNA expression levels (TPM) of all genes in seven human 3D alveolar culture samples. Related to Figure 5 . culture samples. Related to Figure 5 . Table S4 . Twenty single base substitutions of SARS-CoV-2 which were detected in infected human 3D alveolar cultures with MOI of 1 at 3 dpi. Related to Figure 7 . J o u r n a l P r e -p r o o f Single-cell RNA-seq reveals ectopic and aberrant lungresident cell populations in idiopathic pulmonary fibrosis The proximal origin of SARS-CoV-2 Acute and persistent infection of human neural cell lines by human coronavirus OC43 The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice SARS-CoV-2 (COVID-19) by the numbers Type 2 alveolar cells are stem cells in adult lung In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study Isolation and culture of alveolar type II cells STAR: ultrafast universal RNA-seq aligner Cell polarity and spindle orientation in the distal epithelium of embryonic lung Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2 Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention. bioRxiv Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention Organoids as an in vitro model of human development and disease Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons Phylogenetic network analysis of SARS-CoV-2 genomes Emergence of a Wave of Wnt Signaling that Regulates Lung Alveologenesis by Controlling Epithelial Self-Renewal and Differentiation Human Intestinal Organoids Maintain Self-Renewal Capacity and Cellular Diversity in Niche-Inspired Culture Condition HTII-280, a biomarker specific to the apical plasma membrane of human lung alveolar type II cells Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis Modelling Cryptosporidium infection in human small intestinal and lung organoids SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response Early local immune defences in the respiratory tract Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium Bronchiolization of the alveoli in lung cancer: pathology, patterns of differentiation and oncogene expression Human alveolar Type 2 epithelium transdifferentiates into metaplastic KRT5+ basal cells during alveolar repair The Architecture of SARS-CoV-2 Transcriptome Identification of Coronavirus Isolated from a Patient in Korea with COVID-19 Infection and Rapid Transmission of SARS-CoV-2 in Ferrets Challenges in unsupervised clustering of single-cell RNA-seq data VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing Enrichr: a comprehensive gene set enrichment analysis web server 2016 update SARS-CoV-2 productively infects human gut enterocytes The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application Lung stem cell differentiation in mice directed by endothelial cells via a BMP4-NFATc1-thrombospondin-1 axis RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome The Sequence Alignment/Map format and SAMtools Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 Infectious bronchitis virus generates spherules from zippered endoplasmic reticulum membranes The heterogeneous nature of the Coronavirus receptor, angiotensin-converting enzyme 2 (ACE2) in differentiating airway epithelia Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells Human embryonic lung epithelial tips are multipotent progenitors that can be expanded in vitro as long-term self-renewing organoids SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. bioRxiv Type I and Type III Interferons -Induction, Signaling, Evasion, and Application to Combat COVID-19 A new mathematical model for relative quantification in real-time RT-PCR Complexities of Crumbs function and regulation in tissue morphogenesis SARS-CoV-2 targets neurons of 3D human brain organoids Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus Integrative genomics viewer Organization and execution of the epithelial polarity programme Long-term expanding human airway organoids for disease modeling Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs Interferon-stimulated genes: a complex Structural basis of receptor recognition by SARS-CoV-2 Pathogenesis and transmission of SARS-CoV-2 in golden hamsters Comprehensive Integration of Single-Cell Data Generation of human bronchial organoids for SARS-CoV-2 research. bioRxiv Crumbs3-Mediated Polarity Directs Airway Epithelial Cell Fate through the Hippo Pathway Effector Yap A molecular cell atlas of the human lung from single cell RNA sequencing LysoTracker is a marker of differentiated alveolar type II cells Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 Virological assessment of hospitalized patients with COVID-2019 A new coronavirus associated with human respiratory disease in China Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov Systemic analysis of tissue cells potentially vulnerable to SARS-CoV-2 infection by the protein-proofed single-cell RNA profiling of ACE2 SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues We thank Jinwook Choi